PT UBC Medical Indonesia Tbk (ISX:LABS) Stock Based Compensation: Rp0.00 Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PT UBC Medical Indonesia Tbk Stock Based Compensation?

PT UBC Medical Indonesia Tbk ISX:LABS Stock Based Compensation is Rp0.00 Mil as of . 20. The stock has 2 warning signs investors should review.

PT UBC Medical Indonesia Tbk's Stock Based Compensation for the six months ended in . 20 was Rp0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in . 20 was Rp0.00 Mil.

PT UBC Medical Indonesia Tbk Stock Based Compensation Related Terms

PT UBC Medical Indonesia Tbk Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for PT UBC Medical Indonesia Tbk's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT UBC Medical Indonesia Tbk Stock Based Compensation Chart

PT UBC Medical Indonesia Tbk Annual Data
Trend
Stock Based Compensation

PT UBC Medical Indonesia Tbk Semi-Annual Data
Stock Based Compensation

PT UBC Medical Indonesia Tbk Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in . 20 was Rp0.00 Mil.

What does a Stock Based Compensation of Rp0.00 Mil mean?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a Stock Based Compensation of Rp0.00 Mil as of . 20. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for PT UBC Medical Indonesia Tbk and its competitors.
Is PT UBC Medical Indonesia Tbk's Stock Based Compensation too high?
PT UBC Medical Indonesia Tbk's current Stock Based Compensation is Rp0.00 Mil.
How does PT UBC Medical Indonesia Tbk's Stock Based Compensation compare to ABT and SYK?
PT UBC Medical Indonesia Tbk's Stock Based Compensation of Rp0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for PT UBC Medical Indonesia Tbk and its competitors. PT UBC Medical Indonesia Tbk's current Stock Based Compensation is Rp0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT UBC Medical Indonesia Tbk stock overvalued right now?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a current Stock Based Compensation of Rp0.00 Mil. The current Stock Based Compensation is Rp0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For PT UBC Medical Indonesia Tbk (ISX:LABS), the current Stock Based Compensation is Rp0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT UBC Medical Indonesia Tbk Business Description

Address Jl. Rawagelam V, Blok L, No Kav 11-13, Kantor Pusat, Kawasan Industri Pulogadung, Kel. Jatinegara Kec. Cakung, Jakarta Timur, Jakarta, IDN
PT UBC Medical Indonesia Tbk is a distribution company. It engages in wholesale of Laboratory Equipment, Pharmaceutical Equipment, and Medical Equipment for Humans and animals, which includes the wholesale of laboratory equipment, pharmaceutical equipment, and medical equipment. It divides its main marketed medical equipment products into two categories Instruments, in the form of equipment, machines, and analyzers, are used in laboratories. The function of instruments is to process specimens or biological samples to measure and examine the levels of certain substances/contents; and Consumables include single-use medical devices used for treatment or health examinations and Reagents include chemical reagents used in laboratory tests to detect, measure, examine, & produce other substances.